{
    "title": "Sanofi lifts earnings outlook on new drug launches, Dupixent sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12347719/Sanofi-lifts-earnings-outlook-new-drug-launches-Dupixent-sales.html",
    "date": "2023-07-28",
    "keywords": [
        "drug",
        "treatment",
        "currency",
        "burger",
        "drugmaker",
        "dupixent",
        "share",
        "percentage",
        "effect",
        "impact",
        "growth",
        "market",
        "companys",
        "paul",
        "year",
        "july",
        "sanofi",
        "friday",
        "guidance",
        "increase",
        "singledigit",
        "altuviiio",
        "month",
        "therapy",
        "type",
        "part",
        "takeover",
        "provention",
        "bio",
        "marketing",
        "prowess",
        "chance",
        "ceo",
        "hudson",
        "investor",
        "confidence",
        "trial",
        "breast",
        "cancer",
        "candidate",
        "outlook",
        "oneoff",
        "covid19",
        "vaccine",
        "half",
        "decline",
        "business",
        "income",
        "interest",
        "tax",
        "analyst",
        "estimate",
        "website",
        "dollar",
        "value",
        "competition",
        "sclerosis",
        "pill",
        "blood",
        "thinner",
        "lovenox",
        "insulin",
        "product",
        "lantus",
        "revenue",
        "eczema",
        "regeneron",
        "line",
        "christopher",
        "cushing",
        "sonali"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}